IART
Integra LifeSciences HoldingsNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$1.17B
P/E Ratio
—
EPS
$-6.47
Beta
1.08
52W High
$16.49
52W Low
$8.70
50-Day MA
$11.16
200-Day MA
$12.54
Dividend Yield
—
Profit Margin
-30.10%
Forward P/E
6.46
PEG Ratio
0.67
About Integra LifeSciences Holdings
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, limb reconstruction, orthopedics, and general surgery. The company is headquartered in Princeton, New Jersey.
Fundamentals
| Revenue (TTM) | $1.64B |
| Gross Profit (TTM) | $932.69M |
| EBITDA | $308.30M |
| Operating Margin | 10.40% |
| Return on Equity | -38.60% |
| Return on Assets | 2.54% |
| Revenue/Share (TTM) | $21.41 |
| Book Value | $13.39 |
| Price-to-Book | 1.13 |
| Price-to-Sales (TTM) | 0.71 |
| EV/Revenue | 1.793 |
| EV/EBITDA | 14.27 |
| Quarterly Earnings Growth (YoY) | 0.40% |
| Quarterly Revenue Growth (YoY) | 2.40% |
| Shares Outstanding | $77.80M |
| Float | $58.69M |
| % Insiders | 14.41% |
| % Institutions | 100.81% |
Historical Volatility
HV 10-Day
59.36%
HV 20-Day
94.27%
HV 30-Day
84.28%
HV 60-Day
67.90%
HV Rank
81.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($16.71 target)
1
Strong Buy1
Buy4
Hold1
Sell1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026